Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12116423
Ang (1-7) derivative oligopeptides and methods for using and producing the same
granted -
US 12116637
Compositions and methods for detecting and treating high grade subtypes of uterine cancer
granted -
US 12115225
GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof
granted -
US 12116416
Targeting intracellular target-binding determinants with intracellular antibodies
granted -
US 12115163
Combination therapy comprising a MAT2A inhibitor and a type II PRMT inhibitor
granted -
US 12115255
Methods of use of emulsion formulations of an NK-1 receptor antagonist
granted -
US 12116622
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
granted -
US 12116343
Inhibitors of APOL1 and methods of using same
granted -
US 12115166
Corticotropin releasing factor receptor antagonists
granted -
WO 2024209064
NANOÉMULSION SANS PROPYLÈNE GLYCOL
granted -
WO 2024211523
SCHÉMAS POSOLOGIQUES DESTINÉS À ÊTRE UTILISÉS DANS LA PRÉVENTION DE LA RECHUTE DE LA LEUCÉMIE MYÉLOÏDE AIGUË APRÈS UNE TRANSPLANTATION DE CELLULES SOUCHES HÉMATOPOÏÉTIQUES ALLOGÉNIQUES AVEC DU VÉNÉTOCLAX EN COMBINAISON AVEC DE L'AZACITIDINE
granted -
WO 2024209065
NANOÉMULSION SOUS PRESSION
granted -
AU 2023257308
USES OF FARNESOID X RECEPTOR AGONISTS
granted -
US 2024335380
NANOEMULSION WITHOUT PROPYLENE GLYCOL
granted -
US 2024335360
PRESSURIZED NANOEMULSION
granted -
US 12109231
Treatment of neurodegenerative disease with sodium chlorite
granted -
US 12109272
Intermittent dosing of glucocorticoid receptor modulators for the treatment of ovarian and other cancers
granted -
US 12110504
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
granted -
US 12109198
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
granted -
US 12109228
Treatment of neurodegenerative disease with sodium chlorite
granted -
US 12109260
Zika vaccines and immunogenic compositions, and methods of using the same
granted -
US 12109190
Urolithins as immune response enhancers
granted -
US 12109185
Levodopa dosing regimen
granted -
US 12109197
Combinations of β-lactam compounds and probenecid and uses thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.